Personalis (NASDAQ:PSNL) Posts Earnings Results, Misses Estimates By $0.58 EPS
Personalis (NASDAQ:PSNL) released its quarterly earnings results on Tuesday. The company reported ($0.89) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.31) by ($0.58), Briefing.com reports. The company had revenue of $15.80 million during the quarter, compared to analyst estimates of $14.92 million. Personalis’s revenue was up 79.5% compared to the same quarter last year. Personalis updated its FY 2019 guidance to EPS.
Personalis stock opened at $18.79 on Wednesday. The firm has a 50-day simple moving average of $21.50. Personalis has a 12-month low of $14.25 and a 12-month high of $31.88.
In other news, Director Ken Ludlum acquired 70,000 shares of the stock in a transaction that occurred on Monday, June 24th. The stock was purchased at an average cost of $17.00 per share, for a total transaction of $1,190,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Personalis Company Profile
Personalis, Inc operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics.
See Also: Hold Rating
Receive News & Ratings for Personalis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Personalis and related companies with MarketBeat.com's FREE daily email newsletter.